Hope for cannabis as treatment for opioid addiction
Canada currently finds itself at the intersection of two historic social phenomena with massive implications for public health.
Nov 22, 2018
0
13
Canada currently finds itself at the intersection of two historic social phenomena with massive implications for public health.
Nov 22, 2018
0
13
A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and published in the journal Nature Cell Biology examined whether the opening of chromatin (a complex formed by DNA bound to proteins) is the factor ...
Nov 20, 2018
0
7
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...
Nov 16, 2018
0
8
After proving surprisingly beneficial in human clinical trials at the University of Arizona for the treatment of pain resulting from fibromyalgia and migraines, green light therapy now will be tested in a preclinical study ...
Oct 29, 2018
0
0
It is becoming increasingly clear that the placebo effect has a great influence on medical treatment. An international, interdisciplinary team of researchers led by Professor of Health Psychology Andrea Evers from Leiden ...
Jun 28, 2018
0
5
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the selection of specific categories of devices when endovascular therapy (EVT) is indicated. The purpose of this ...
Apr 25, 2018
0
3
(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).
Apr 23, 2018
0
4
Professor Chris Butler of the University of Oxford's Nuffield Department of Primary Care Health Sciences, and GP in the Cwm Taf University Health Board in Wales, is the lead investigator in the world's largest clinical trial ...
Jan 26, 2018
0
1
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.
Nov 15, 2017
0
13
Patients with advanced neuroendocrine tumors (NETs) reported similar health-related quality of life (HRQOL) during treatment with a recently approved chemotherapy drug as compared to patients receiving a placebo treatment, ...
Nov 6, 2017
0
1